Ozurdex
What it is used for
OZURDEX is indicated for the treatment of:,- Diabetic macular oedema (DME),- Macular oedema due to Branch Retinal Vein Occlusion (BRVO) or Central Retinal Vein Occlusion (CRVO).,- Non-infectious uveitis affecting the posterior segment of the eye.,OZURDEX is indicated for the treatment of diabetic macular oedema (DME).
How to take it
The way to take this medicine is: Intravitreal-Within The Vitreous Cavity Of The Eye.
- Store below 25 degrees Celsius
- Protect from Heat
- Shelf lifetime is 36 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
How to take it
The way to take this medicine is: Intravitreal-Within The Vitreous Cavity Of The Eye.
- Store below 25 degrees Celsius
- Protect from Heat
- Shelf lifetime is 36 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Pregnant or planning a pregnancy?
For the active ingredient dexamethasone
This medicine is generally considered safe during pregnancy if taken as directed. During pregnancy, you should discuss your medicine use with your doctor or pharmacist.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Visual appearance
Rod-shaped, solid implant in a single use applicator
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on March 1, 2020. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.